EoCene Ltd. (EOCN) stock
EOCNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 31, 2026Score 5/30
$1.75−0.45 (-20.40%)
Close on Nov 19, 2026Market cap $1.75MP/E –Yield –
EoCene operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
For fiscal 2020 it was -$30.21M.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | -$30.21M | – |
| FY2019 | Dec 31, 2019 | -$22.38M | – |
| FY2018 | Dec 31, 2018 | -$10.72M | – |
| FY2017 | Dec 31, 2017 | -$12.36M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2020 | Jun 30, 2020 | -$5.82M | – |
| Q2 FY2019 | Jun 30, 2019 | -$4.70M | – |
See a number that looks wrong?